We and others have shown that interactions with integrins and FN at the plasma membrane are essential to activating “outside-in” signaling (FAK, Akt, β-catenin, Src, epidermal growth factor receptor/EGFR) [34,45] and are clearly implicated in cancer metastasis and stemness. The gene discussed is PTK2; the disease is cancer.